Euronext NV
PAR:ENX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Euronext NV
PAR:ENX
|
NL |
|
R
|
Reata Pharmaceuticals Inc
F:2R3
|
US |
|
Low Keng Huat (Singapore) Ltd
SGX:F1E
|
SG |
Intrinsic Value
The
intrinsic value for
Euronext NV (ENX)
under the Base Case is
122.4
EUR.
Compared with the current market price of 143.3 EUR, the stock appears
Overvalued by 15%.
Both DCF and multiples point to overvaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Euronext NV.
The
intrinsic value for
Euronext NV (ENX)
under the Base Case is
122.4
EUR.
Compared with the current market price of 143.3 EUR, the stock appears Overvalued by 15%.